Israeli Research SEP 30, 2025
WATCH: Israeli Company Achieves First Catheter-Only Implant in Groundbreaking Heart Valve Trial
The company emphasized the significance of this milestone for patients worldwide who are unable to undergo either open-heart surgery or existing transcatheter therapies.
TruLeaf Medical, an Israeli biomedical company owned by Allmed Solutions, has completed the first stage of a first-in-human trial involving a new approach to heart valve replacement.
The company reported that on September 5, doctors in India implanted its RoseDoc docking device in two patients with advanced heart failure, both of whom had no remaining treatment options.
The procedure marked the first time the RoseDoc system has been used in humans.
Read more
Did you find this article interesting?